B12 and D Vitamins very low (bloodwork showed 15 for D). Dutasteride and Minoxidil not holding back the hairloss. Should i supplement?
    12/19/2025

    From the encyclopedia
    Dutasteride →

    5-alpha reductase inhibitor that blocks both enzyme types, a stronger DHT blocker than finasteride

    Minoxidil →

    Vasodilator used on the scalp and, at low doses, as a tablet

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    💊 Dutasteride (oral) 0.5mg almost a year and a half
    💊 Minoxidil (oral) 2.5mg almost a year and a half
    the tone is 😞 negative with not effectively preventing hair loss results.

    Other terms

    Dutasteride and Minoxidil are not effectively preventing hair loss. Supplementing with Vitamin D and B12 is recommended.
    View this post in the Community →

    Similar Community Posts Join

    5 / 5 results

      community Oral Dut/Minoxidil for two years - no results.

       102 upvotes 1 year ago
      The user has used oral Dutasteride and Minoxidil for two years without regrowth, despite trying Finasteride and supplements. They consider increasing Minoxidil, adding microneedling, and switching medications, while others suggest RU58841, a hair transplant, or checking for other hair loss causes.

      community Ok, let's debunk Dutasteride not working forever!

      in Finasteride/Dutasteride  69 upvotes 1 month ago
      Dutasteride may not work as effectively as finasteride for everyone, with some users experiencing increased shedding or no improvement. Combining treatments like minoxidil with dutasteride or finasteride can help maintain or improve hair growth, but individual results vary.

      community It's over- 8 months in & I've got 0 progress from Dutasteride

       38 upvotes 7 months ago
      The user tried Dutasteride, Finasteride, and Minoxidil for hair loss but saw no improvement after nearly two years, feeling frustrated and considering giving up. Other users suggested trying different dosages, oral Minoxidil, RU58841, or considering a hair transplant, while some noted that stabilization without regrowth is common.

      community 2 years of dut, 1 year of loss 24m

       515 upvotes 6 months ago
      The user experienced hair regrowth with dutasteride but later lost progress despite using minoxidil foam and dermastamping. Suggestions included reducing dermastamping frequency, conducting blood tests, and considering oral minoxidil or different brands of dutasteride.

    Related Research

    6 / 6 results

      research Hair Loss in Women

      81 citations , March 2009 in “Seminars in Cutaneous Medicine and Surgery”
      This review discusses the classifications, diagnostic methods, and treatment strategies for female pattern hair loss, but reports no clinical results.

      research A Review on Drug Induced Alopecia

      January 2022 in “International Journal of Science and Research (IJSR)”
      This article reviews drug-induced alopecia, its diagnosis, and treatments, but presents no new clinical findings.

      research Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique

      March 2025 in “HAL (Le Centre pour la Communication Scientifique Directe)”
      This thesis investigates the underlying mechanisms and treatment options for androgenetic alopecia, highlighting the molecular roles of androgens and genetic predispositions, and evaluates current and emerging therapies, such as PROTACs and Janus Kinase inhibitors, to enhance patient management.

      research Lipid nanocarriers as innovative strategies for hair regrowth

      June 2026 in “Discover Nano”
      This review discusses current treatment strategies for alopecia and highlights the potential of lipid-based nanoparticles to improve drug delivery to the scalp and hair follicles, noting their ability to enhance skin penetration and drug stability while outlining associated challenges and the need for further research.

      research Pharmacodynamic Evaluation: Endocrinology

      January 2017
      This chapter reviews pharmacodynamic evaluations in endocrine disorders focusing on oral antidiabetics, insulin analogues, and hormone interactions, but reports no new results.